Evidence map›Paper›PMID 28811660›Full record

ArticleScientific reports2017

Transcription factor ZNF148 is a negative regulator of human muscle differentiation.

Jesse Bakke, William C Wright, Anthony E Zamora, Su Sien Ong, Yue-Ming Wang, Jessica D Hoyer, Christopher T Brewer, Paul G Thomas, Taosheng Chen

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jesse BakkeDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
William C WrightDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Anthony E ZamoraDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Su Sien OngDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Yue-Ming WangDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Jessica D HoyerDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Christopher T BrewerDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Paul G ThomasDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.ORCID 0000-0001-7955-0256
Taosheng ChenDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. taosheng.chen@stjude.org.
St. Jude Children's Research Hospital · US

Funding

Regulation of xenobiotic receptors PXR and CAR: implications in drug dispositionR35GM118041 · NIGMS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Taosheng Chen · 2016 to 2026
$4.3M
Regulation of drug disposition by a novel microRNA-mediated pathwayR01GM110034 · NIGMS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHEN, TAOSHENG · 2014 to 2016
$998k
NIGMS NIH HHS R01 GM110034NIGMS NIH HHS R35 GM118041
6 · The paper itself

Abstract

Muscle differentiation is a complex process in which muscle progenitor cells undergo determination and eventually cellular fusion. This process is heavily regulated by such master transcription factors as MYOD and members of the MEF2 family. Here, we show that the transcription factor ZNF148 plays a direct role in human muscle cell differentiation. Downregulation of ZNF148 drives the formation of a muscle phenotype with rapid expression of myosin heavy chain, even in proliferative conditions. This phenotype was most likely mediated by the robust and swift upregulation of MYOD and MEF2C.

Indexed as

Cell DifferentiationGene Expression RegulationMuscle, SkeletalCell LineCell Line, TransformedDNA-Binding ProteinsGene Expression ProfilingGene Knockdown TechniquesHumansMuscle DevelopmentMyoblastsMyoD ProteinPhenotypeRNA, Small InterferingTranscription FactorsDNA-Binding ProteinsMyoD ProteinRNA, Small InterferingTranscription FactorsZNF148 protein, human

Identifiers

PMID28811660
PMCPMC5557752
OpenAlexW2744561083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.